Pular para o conteúdo
Merck

Rat atrial responses to Bothrops jararacussu (jararacuçu) snake venom.

Toxicology (2014-06-29)
Mariana A P Rodrigues, Lourdes Dias, André L Rennó, Norma C Sousa, Adriana Smaal, Delano A da Silva, Stephen Hyslop
RESUMO

Envenoming by the pitviper Bothrops jararacussu produces cardiovascular alterations, including coagulopathy, systemic hemorrhage, hypotension, circulatory shock and renal failure. In this work, we examined the activity of this venom in rat isolated right atria. Incubation with venom (0.025, 0.05, 0.1 and 0.2mg/ml) caused concentration-dependent muscle contracture that was not reversed by washing. Muscle damage was seen histologically and confirmed by quantification of creatine kinase-MB (CK-MB) release. Heating and preincubation of venom with p-bromophenacyl bromide (a phospholipase A2 inhibitor) abolished the venom-induced contracture and muscle damage. In contrast, indomethacin, a non-selective inhibitor of cyclooxygenase, and verapamil, a voltage-gated Ca(2+) channel blocker, did not affect the responses to venom. Preincubation of venom with Bothrops or Bothrops/Crotalus antivenom or the addition of antivenom soon after venom attenuated the venom-induced changes in atrial function and tissue damage. These results indicate that B. jararacussu venom adversely affected rat atrial contractile activity and muscle organization through the action of venom PLA2; these venom-induced alterations were attenuated by antivenom.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Indometacina, 98.5-100.5% (in accordance with EP)
Sigma-Aldrich
Creatine Phosphokinase from rabbit muscle, Type I, salt-free, lyophilized powder, ≥150 units/mg protein
Sigma-Aldrich
(±)-Verapamil hydrochloride, ≥99% (titration), powder
Sigma-Aldrich
2,4′-Dibromoacetophenone, >98%
Sigma-Aldrich
Creatine Phosphokinase from bovine heart, Type III, salt-free, lyophilized powder, ≥30 units/mg protein
Sigma-Aldrich
Indometacina, meets USP testing specifications
Supelco
Verapamil hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Indometacina, Pharmaceutical Secondary Standard; Certified Reference Material
Verapamil hydrochloride, European Pharmacopoeia (EP) Reference Standard
Supelco
(±)-Verapamil hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
2,4′-Dibromoacetophenone, for HPLC derivatization, LiChropur, ≥99.0% (HPLC)
Indometacina, European Pharmacopoeia (EP) Reference Standard